Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance

Go back to Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance
NEOGENOMICS (NASDAQ: NEO) Delayed: 16.16 +0.22 (1.38%)
Previous Close $15.94    52 Week High $9.54 
Open $15.72    52 Week Low $5.49 
Day High $16.36    P/E 404.00 
Day Low $15.72    EPS $0.04 
Volume 1,137,478